Skip to content
10-Q

Quarterly Report

Echo Therapeutics, Inc.

0001415889-16-006001

← back to feed
Filed
May 20, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 2, 2016 11.4M sh
Operating Cash Flow Q1 2016 · Mar 31, 2016 −$1.81M
Operating Cash Flow restated Q1 2016 · Mar 31, 2015 −$2.02M
Cash And Equivalents Q1 2016 · Mar 31, 2016 $42.83K
Cash And Equivalents Q1 2016 · Dec 31, 2015 $56.21K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $469.49K
Cash And Equivalents Q1 2016 · Dec 31, 2014 $1.28M
Stockholders Equity Q1 2016 · Mar 31, 2016 −$4.77M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$2.53M
Current Liabilities Q1 2016 · Mar 31, 2016 $5.66M
Current Liabilities Q1 2016 · Dec 31, 2015 $3.24M
Total Liabilities Q1 2016 · Mar 31, 2016 $5.76M
Total Liabilities Q1 2016 · Dec 31, 2015 $3.33M
Current Assets Q1 2016 · Mar 31, 2016 $374.93K
Current Assets Q1 2016 · Dec 31, 2015 $300.74K
Total Assets Q1 2016 · Mar 31, 2016 $986.23K
Total Assets Q1 2016 · Dec 31, 2015 $805.09K
Sga Expense Q1 2016 · Mar 31, 2016 $936.63K
Sga Expense restated Q1 2016 · Mar 31, 2015 $1.54M
Rd Expense Q1 2016 · Mar 31, 2016 $689.02K
Rd Expense restated Q1 2016 · Mar 31, 2015 $770.1K
Net Income Q1 2016 · Mar 31, 2016 −$2.62M
Net Income Q1 2016 · Mar 31, 2015 −$8.3M
Operating Income Q1 2016 · Mar 31, 2016 −$1.66M
Operating Income Q1 2016 · Mar 31, 2015 −$2.51M